mosapride
Selected indexed studies
- Mosapride in gastrointestinal disorders. (Drugs, 2008) [PMID:18457463]
- Mosapride-Induced Movement Disorders. (J Mov Disord, 2022) [PMID:35531622]
- Mosapride treatment for functional dyspepsia: a meta-analysis. (J Gastroenterol Hepatol, 2015) [PMID:25041564]
_Worker-drafted node — pending editorial review._
Connections
mosapride is a side effect of
Sources
- Mosapride in gastrointestinal disorders. (2008) pubmed
- Mosapride-Induced Movement Disorders. (2022) pubmed
- Mosapride treatment for functional dyspepsia: a meta-analysis. (2015) pubmed
- Mosapride stimulates human 5-HT(4)-serotonin receptors in the heart. (2024) pubmed
- Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review. (2013) pubmed
- Efficacy and safety of Bifidobacterium quadruple viable tablets combined with mosapride citrate in the treatment of constipation in China: a systematic review and meta-analysis. (2023) pubmed
- [Pharmacological effects of the gastroprokinetic agent mosapride citrate]. (1999) pubmed
- Prokinetics for the treatment of functional dyspepsia: an updated systematic review and network meta-analysis. (2023) pubmed
- Mosapride and postoperative ileus. (2009) pubmed
- Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis. (2020) pubmed